7 Implementation and audit
7.1 When NICE recommends a treatment 'as an option', the NHS must make sure it is available within 3 months of this guidance being published. This means that, if a patient has depression and anxiety and the doctor responsible for their care thinks that computerised cognitive behaviour therapy is the right treatment, it should be available for use, in line with NICE's recommendations.
7.2 NHS organisations that offer treatment for people with depression and anxiety and general practitioners should review their current practice and policies to take account of the guidance set out in Section 1.
7.3 Local guidelines, protocols or care pathways that refer to the care of people with depression or anxiety should incorporate the guidance.
7.4 To measure compliance locally with the guidance, the following criteria could be used. Further details on suggestions for audit are presented in Appendix C.
7.4.1 A person with mild or moderate depression is offered Beating the Blues as an option for the management of the condition as outlined in the current NICE clinical guideline for the stepped-care management of depression in primary and secondary care.
7.4.2 A person with depression is offered CCBT with COPE or Overcoming Depression only as part of an ongoing or new clinical trial that is designed to generate robust and relevant data on the clinical effectiveness of these specific CCBT packages.
7.4.3 A person with panic or phobia is offered the option of FearFighter as an option for the management of the condition as outlined in the current NICE clinical guideline for the stepped-care management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in primary, secondary and community care.
7.4.4 A person with OCD is not offered CCBT with OCFighter. A person who is currently using OCFighter as routine therapy or as part of a clinical trial should have the option to continue on therapy until the person, or the GP and/or specialist, consider it appropriate to stop.